News
Join us at the Live Spotlight Session at DIA Europ...
Quinten Health will speak at DIA Europe 2023 at the Congress Center Basel, Switzerland.Quinten Health will animate a Live Session about "Faster...
Quinten Health innovates at DIA Basel 2023 with Re...
We are thrilled to announce that March 23rd, Quinten Health will animate a 𝗟𝗶𝘃𝗲 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 at 𝗗𝗜𝗔 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟯.Billy Amzal, CEO of Quinten Health and...
Don’t miss us at DIA Europe 2023!
Quinten Health will be at the DIA Europe 2023 at the Congress Center Basel in Switzerland.From 22 March to 24 March, 2023 we will be at DIA...
Our new clustering method “Qluster” is out!
Discover our new article "Qluster" referring to a generic and robust method of clustering health data. Already applied on many projects, this...
Discover our new work around patients’ perce...
The poster "𝘼 𝙉𝙖𝙩𝙪𝙧𝙖𝙡 𝙇𝙖𝙣𝙜𝙪𝙖𝙜𝙚 𝙋𝙧𝙤𝙘𝙚𝙨𝙨𝙞𝙣𝙜 (#𝙉𝙇𝙋) 𝘼𝙥𝙥𝙧𝙤𝙖𝙘𝙝 𝙩𝙤 𝘼𝙪𝙩𝙤𝙢𝙖𝙩𝙚 𝙋𝙖𝙩𝙞𝙚𝙣𝙩𝙨’ 𝙏𝙚𝙨𝙩𝙞𝙢𝙤𝙣𝙞𝙖𝙡𝙨 𝘼𝙣𝙖𝙡𝙮𝙨𝙞𝙨" was written in collaboration with Mélissa...
Our team will present a poster at Journées de Bio...
Quinten Health will be at the Journées de Biostatiques 2022 in Rennes, at the INSA School.Mélissa Rollot (Manager Data Scientist) and Coriande...
We will speak at BiotechX 2022
Quinten Health will be at the Biotech X 22 at Basel Congress Center, Switzerland.Alexandre Templier (President and co-founder) and Frank Ahrens...
Our team will be at ISPOR Europe 2022
Quinten Health will be at ISPOR Europe 2022 in Vienna.Billy Amzal (CEO) will be at ISPOR Europe 2022 from Nov. 6th to Nov. 9th 2022 in Vienna,...
Quinten Health is now OMOP certified by EHDEN (the...
Quinten Health is certified by the European Health Data & Evidence Network (EHDEN) Consortium after their fourth and final call ! This...
Quinten Health, Deeplink Medical, and Institut de ...
Paris, November 15th, 2021 – The partnership will allow INCa (Institut National du Cancer) accredited hospitals of early phase (CLIP) and to...
Aetion and Quinten Health partner to use AI and RW...
Partnership enables global biopharma companies, regulatory agencies, and payers to generate and validate novel insights leveraging real-world...
Key insights from VivaTech 2021 for a pharmaceutic...
We attended Viva Tech 2021 at Sanofi’s booth where we were invited as a preferred partner in artificial intelligence (AI) applied to healthcare....
Quinten Health Partners with Certara to Advance Pr...
Paris, May 27, 2021 – Quinten Health today announced that it is collaborating with Certara, Inc. to offer a unique end-to-end suite of...
Euresis Partners & Quinten Health joined forc...
Paris, April 22, 2021 – Mastering uncertainty has never been so important for healthcare manufacturers. Whether for clinical development, market...
Gustave Roussy and Quinten Health signed a researc...
Paris, March 17, 2021 – After decades of innovation and research in immunotherapy, researchers recently turned to a promising new therapeutic...
Quinten spins off 50 data scientists to become a g...
Following the launch of PharmIA, an awarded¹ software to augment and facilitate the prescriptions review by hospital pharmacists, Quinten now...
Big Data: a new therapeutic option? Part 6: AI-aug...
From Data to Artificial Intelligence in healthcareFollowing Part 5: The future of pharma 6) From Data to Artificial Intelligence Big Data will...
Big Data: a new therapeutic option? Part 5: The fu...
What is the future for the pharmaceutical industry?Following Part 4: Predict or cure? 5) What future for the pharmaceutical industry? This...
Big Data: a new therapeutic option? Part 4: Predic...
Personalized medicine. Predict or cure: do we need to choose?Following Part 3: Data as raw material 4) Personalized medicine: predict or cure -...
Big Data: a new therapeutic option? Part 3: Data a...
Data as an inexhaustible resource, the expert’s raw materialFollowing Part 2: The end of averaging 3) Data: an inexhaustible resource - the...
Big Data: a new therapeutic option? Part 2: The en...
All similar, yet so different: the end of averagingFollowing Part 1: Know thyself 2) All different and yet so similar - the end of "averaging" We...